Market Research Industry Reports

Interface Biologics Inc - Product Pipeline Analysis, 2018 Update

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Interface Biologics Inc (IBI) is a medical device company that develops transformative biomedical polymer technologies. The company offers anti-thrombogenic and combination drug delivery devices. Its anti-thrombogenic additives reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery platforms. IBIs technologies include endexo, kinesyx and epidel. The company provides combination drug delivery devices which include Epidel and Kinesyx. Its products improve the safety and effectiveness of implantable medical devices. The company serves dialysis patients in Canada and abroad. IBI is headquartered in Toronto, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Interface Biologics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



List of Tables 3
List of Figures 3
Interface Biologics Inc Company Overview 4
Interface Biologics Inc Company Snapshot 4
Interface Biologics Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Interface Biologics Inc Pipeline Analysis Overview 6
Interface Biologics Inc - Key Facts 6
Interface Biologics Inc - Major Products and Services 7
Interface Biologics Inc Pipeline Products by Development Stage 8
Interface Biologics Inc Pipeline Products Overview 9
EPICUFF 9
EPICUFF Product Overview 9
EPISCREW - Dental Implant 10
EPISCREW - Dental Implant Product Overview 10
EPISCREW - Orthopedic Fixation Device 11
EPISCREW - Orthopedic Fixation Device Product Overview 11
Interface Biologics Inc - Key Competitors 12
Interface Biologics Inc - Key Employees 13
Interface Biologics Inc - Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Interface Biologics Inc, Recent Developments 15
Feb 14, 2011: Interface Biologics Appoints Art Rosenthal To Chairman Of Board Of Directors 15
Oct 26, 2010: Interface Biologics Receives ISO 13485:2003 Certification 15
Dec 09, 2008: Interface Appoints President And Board Member 15
Aug 25, 2007: Interface Appoints New Advisory Board Member 16
May 08, 2007: Interface Appoints New Advisory Board Member 16
Appendix 17
Methodology 17
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables

List of Tables
Interface Biologics Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Interface Biologics Inc Pipeline Products by Equipment Type 5
Interface Biologics Inc Pipeline Products by Indication 5
Interface Biologics Inc, Key Facts 6
Interface Biologics Inc, Major Products and Services 7
Interface Biologics Inc Number of Pipeline Products by Development Stage 8
Interface Biologics Inc Pipeline Products Summary by Development Stage 8
EPICUFF - Product Status 9
EPICUFF - Product Description 9
EPISCREW - Dental Implant - Product Status 10
EPISCREW - Dental Implant - Product Description 10
EPISCREW - Orthopedic Fixation Device - Product Status 11
EPISCREW - Orthopedic Fixation Device - Product Description 11
Interface Biologics Inc, Key Employees 13
Glossary 19

List Of Figures

List of Figures
Interface Biologics Inc Pipeline Products by Equipment Type 5
Interface Biologics Inc Pipeline Products by Development Stage 8

Interface Biologics Inc - Product Pipeline Analysis, 2018 Update

Interface Biologics Inc (IBI) is a medical device company that develops transformative biomedical polymer technologies. The company offers anti-thrombogenic and combination drug delivery devices. Its anti-thrombogenic additives reduce thrombosis in

USD 750View Report

Global Haptic Interface Device Market Research Report 2018

Haptic Interface Device Report by Material, Application, and Geography Global Forecast to 2022 is a professional and in-depth research report on the worlds major regional market conditions, focusing on

USD 2850View Report

Synthetic Biologics Inc (SYN) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Synthetic Biologics Inc (Synthetic Biologics), formerly Adeona Pharmaceuticals Inc is a clinical company that develops novel therapeutics to treat gut microbiome. The companys pipeline products include SYN-004 and SYN-010. Its

USD 250View Report

Synthetic Biologics Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Synthetic Biologics Inc Company Profile is a detailed strategic and analytical report on Synthetic Biologics Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF USD 750    USD 600
  • Site Licence USD 1500    USD 1200
  • Enterprise Wide Licence USD 2250    USD 1800
$ 600

Reports Details

Published Date : Jul 2018
No. of Pages :20
Country :Canada
Category :Medical Devices
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube